title: [Limited evidence for monitoring and treatment of hypophosphataemia in critically ill patients].
abstract: Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.
authors.affiliation: christine.kinggaard.federspiel.02@regionh.dk.
authors.forename: Christine
authors.initials: C
authors.lastname: Federspiel
authors.forename: Theis S
authors.initials: TS
authors.lastname: Itenov
authors.forename: Katrin
authors.initials: K
authors.lastname: Thormar
authors.forename: Morten H
authors.initials: MH
authors.lastname: Bestle
mesh_terms: D016638:Critical Illness; D019317:Evidence-Based Medicine; D006801:Humans; D017674:Hypophosphatemia / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D007362:Intensive Care Units; D010710:Phosphates / Q000378:metabolism / Q000627:therapeutic use
chemical_list: D010710:Phosphates